IMS
Click for more information
0.00% 69.0¢ impelus limited

Ann: FY16 Results Ahead of Guidance - Revenue and EBITDA up-MBE.AX, page-8

  1. pods
    4,092 Posts.
    lightbulb Created with Sketch. 208
    clock Created with Sketch.
    09/08/16
    10:46
    Post #: 18474788
    Revenue guidance was >60m. So revenue is not ahead of guidance, but i believe EBIDTA and NPAT are. From memory.
    MBE Price at posting: 36.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

MIN MinRes jumps 5% as the company meets production guidance – depressed iron ore prices be damned
right-arrow Created with Sketch.
RHK Red Hawk upgrades Blacksmith with DSO mineral resource at the Eagle Deposit
right-arrow Created with Sketch.
FMG Quarterly & half yearly reports: Drives Newmont up, Ampol flat, while Fortescue plunges 2.6%
right-arrow Created with Sketch.
BGL Bellevue aims for 45% production increase by FY 2028, announces $150M placement
right-arrow Created with Sketch.
TRP Tissue Repairs soars nearly 32% on TGA approval for wound healing gel
right-arrow Created with Sketch.
NEWS Capital raisings wrap: Brainchip, Ovanti, Lake and VHM
right-arrow Created with Sketch.
watchlist Created with Sketch. Add IMS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.